Ablation for atrial fibrillation in heart failure with preserved function
Part of Heart & circulation clinical trials.
This trial tests whether a catheter procedure that treats atrial fibrillation works better than standard care for people with heart failure with preserved ejection fraction. It aims to improve heart rhythm symptoms and overall outcomes compared with conventional treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You can sign informed consent and follow the study visits
- You have symptomatic heart failure (NYHA class II or III)
- You have atrial fibrillation that is paroxysmal or persistent, diagnosed less than 24 months ago
- Your heart pumping strength (LVEF) is in a specific range: 40–49%, or 50% or higher with certain echo changes
- Your atrial fibrillation and heart failure are recent/active enough based on hospitalizations and/or blood test results (NT-proBNP)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a procedure called catheter ablation (which fixes the heart's electrical signals) can help people with heart failure and atrial fibrillation. It focuses on those whose heart pumping strength is mildly reduced or preserved (above 40%).
This study tests whether a catheter ablation procedure can help people with atrial fibrillation and a kind of heart failure where the heart pumps normally but doesn't relax properly (HFpEF). It looks at whether the procedure can improve symptoms and heart function.
This trial tests whether early catheter ablation (a procedure to fix irregular heartbeats) helps people who have both heart failure and atrial fibrillation. It looks at how this treatment affects your heart function and quality of life.
This trial compares two ways to treat atrial fibrillation in people with heart failure where the heart's pumping strength is still normal. You'll either get a procedure called ablation to restore normal rhythm or medication to control your heart rate. The goal is to see which approach works better for people like you.
This trial tests a new catheter system to treat atrial fibrillation (AF) by creating small scars in the heart to block faulty signals. It may help people with symptoms that continue despite medication and who are scheduled for a standard ablation procedure.
This trial looks at whether a special heart rhythm treatment called “ablation” works well when done during certain heart operations. It may help reduce atrial fibrillation (AF) symptoms or future abnormal rhythm episodes for people who are already having surgery.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.